| Professional Services Industry | Industrials Sector | Mr. Joakim Granemo CEO | XFRA Exchange | SE0000885501 ISIN |
| DE Country | 13 Employees | - Last Dividend | - Last Split | - IPO Date |
Level Bio AB, formerly known as AlphaHelix Molecular Diagnostics AB, is a company that undertakes the design, development, and international distribution of diagnostic products, specializing in the Nordic region. Founded in 1998 and headquartered in Stockholm, Sweden, Level Bio AB focuses on delivering high-quality equipment, consumables, and reagents for molecular biology, alongside research and diagnostic products primarily in Sweden and the Nordic countries. Its mission extends to developing advanced diagnostic solutions for genetic fetal diagnostics as well as tackling challenges related to genetic miscarriage and infertility. Furthermore, Level Bio is committed to innovation in congenital heart defect diagnostics. The name change to Level Bio AB took effect in May 2024, marking a new phase in the company's evolution while continuing its tradition of excellence and innovation in the field of molecular diagnostics.